These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1989686)

  • 1. Characterization of the kinetic pathway for fibrin promotion of alpha-thrombin-catalyzed activation of plasma factor XIII.
    Naski MC; Lorand L; Shafer JA
    Biochemistry; 1991 Jan; 30(4):934-41. PubMed ID: 1989686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catalytic competence of human alpha- and gamma-thrombin in the activation of fibrinogen and factor XIII.
    Lewis SD; Lorand L; Fenton JW; Shafer JA
    Biochemistry; 1987 Dec; 26(24):7597-603. PubMed ID: 3427095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steady state kinetic parameters for the thrombin-catalyzed conversion of human fibrinogen to fibrin.
    Higgins DL; Lewis SD; Shafer JA
    J Biol Chem; 1983 Aug; 258(15):9276-82. PubMed ID: 6409903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-thrombin-catalyzed hydrolysis of fibrin I. Alternative binding modes and the accessibility of the active site in fibrin I-bound alpha-thrombin.
    Naski MC; Shafer JA
    J Biol Chem; 1990 Jan; 265(3):1401-7. PubMed ID: 2295636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promotion of thrombin-catalyzed activation of factor XIII by fibrinogen.
    Janus TJ; Lewis SD; Lorand L; Shafer JA
    Biochemistry; 1983 Dec; 22(26):6269-72. PubMed ID: 6661434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of formation of factor XIIIa by its fibrin substrates.
    Lewis SD; Janus TJ; Lorand L; Shafer JA
    Biochemistry; 1985 Nov; 24(24):6772-7. PubMed ID: 2866798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening cleavage of Factor XIII V34X Activation Peptides by thrombin mutants: A strategy for controlling fibrin architecture.
    Jadhav MA; Goldsberry WN; Zink SE; Lamb KN; Simmons KE; Riposo CM; Anokhin BA; Maurer MC
    Biochim Biophys Acta Proteins Proteom; 2017 Oct; 1865(10):1246-1254. PubMed ID: 28687225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of factor XIII with fibrin as substrate and cofactor.
    Hornyak TJ; Shafer JA
    Biochemistry; 1992 Jan; 31(2):423-9. PubMed ID: 1731900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the fibrin polymer structure that accelerates thrombin cleavage of plasma factor XIII.
    Greenberg CS; Achyuthan KE; Rajagopalan S; Pizzo SV
    Arch Biochem Biophys; 1988 Apr; 262(1):142-8. PubMed ID: 2895608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing interactions between the coagulants thrombin, Factor XIII, and fibrin(ogen).
    Maurer MC; Trumbo TA; Isetti G; Turner BT
    Arch Biochem Biophys; 2006 Jan; 445(1):36-45. PubMed ID: 16364233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor XIIIa formation promoted by complexing of alpha-thrombin, fibrin, and plasma factor XIII.
    Greenberg CS; Achyuthan KE; Fenton JW
    Blood; 1987 Mar; 69(3):867-71. PubMed ID: 2880615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The polymerization and thrombin-binding properties of des-(B beta 1-42)-fibrin.
    Siebenlist KR; DiOrio JP; Budzynski AZ; Mosesson MW
    J Biol Chem; 1990 Oct; 265(30):18650-5. PubMed ID: 2211727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The COOH-terminal domain of hirudin. An exosite-directed competitive inhibitor of the action of alpha-thrombin on fibrinogen.
    Naski MC; Fenton JW; Maraganore JM; Olson ST; Shafer JA
    J Biol Chem; 1990 Aug; 265(23):13484-9. PubMed ID: 2380171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of gamma A/gamma ' fibrinogen in plasma factor XIII activation.
    Moaddel M; Falls LA; Farrell DH
    J Biol Chem; 2000 Oct; 275(41):32135-40. PubMed ID: 10913112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of low specificity and cofactor interaction sites on thrombin during factor XIII activation. Competition for cofactor sites on thrombin determines its fate.
    Philippou H; Rance J; Myles T; Hall SW; Ariens RA; Grant PJ; Leung L; Lane DA
    J Biol Chem; 2003 Aug; 278(34):32020-6. PubMed ID: 12794066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombin activity is unaltered by N-terminal truncation of factor XIII activation peptides.
    Isetti G; Maurer MC
    Biochemistry; 2004 Apr; 43(14):4150-9. PubMed ID: 15065858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release of fibrinopeptides by the slow and fast forms of thrombin.
    Vindigni A; Di Cera E
    Biochemistry; 1996 Apr; 35(14):4417-26. PubMed ID: 8605191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examining thrombin hydrolysis of the factor XIII activation peptide segment leads to a proposal for explaining the cardioprotective effects observed with the factor XIII V34L mutation.
    Trumbo TA; Maurer MC
    J Biol Chem; 2000 Jul; 275(27):20627-31. PubMed ID: 10801785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of fibrin polymers on thrombin-catalyzed plasma factor XIIIa formation.
    Greenberg CS; Miraglia CC
    Blood; 1985 Aug; 66(2):466-9. PubMed ID: 2861869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure.
    Ariëns RA; Philippou H; Nagaswami C; Weisel JW; Lane DA; Grant PJ
    Blood; 2000 Aug; 96(3):988-95. PubMed ID: 10910914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.